Determinants of Compliance With Glaucoma Therapy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01484392

Enrollment

Registered

2011-12-02

Start date

2006-08-31

Completion date

2013-12-31

Last updated

2016-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open Angle Glaucoma

Keywords

open angle glaucoma, compliance, adherence

Brief summary

The purpose of this study is to determine which medical, demographic, and health belief factors are associated with glaucoma therapy compliance.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* open angle glaucoma * be well controlled on current medical therapy * be using a prostaglandin analogue

Design outcomes

Primary

Measure	Time frame	Description
Compliance with glaucoma medication at 1 month	1 month after enrollment	Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.
Compliance with glaucoma medication at 3 months	3 months after enrollment	Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.

Countries

United States

Outcome results